Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2012-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
NCT03724331
Quality of Life in Lung Cancer Survivors
NCT00586937
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
NCT03089125
The Transitions Project: Efficacy Trial
NCT05087251
Improving Supportive Care For Patients With Thoracic Malignancies
NCT03216109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lifestyle counseling
This is a single arm, quasi-experimental, pre- and post- test study design to test the feasibility and acceptability of a multiple risk factor, lifestyle intervention in patients receiving surgical treatment for lung cancer or those suspected of having lung cancer.
Lifestyle counseling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle counseling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* MD approval to participate in study
* Meets one of the inclusions below:
* 1\. a histological diagnosis of NSCLC undergoing potentially curative treatment
* 2\. OR those undergoing surgical procedures for lung cancer (includes patients undergoing diagnostic testing or those presenting with lung nodules
* 3.OR patients who have had a surgical procedure for lung cancer within the last six months.
* May invite a buddy to join study with them defined as a friend, partner, adult child or sibling
* ≥ 21 years of age,
* English speaking, who is invited by the subject to join as a support person (e.g., friend, partner, adult child or sibling)
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
University of Massachusetts, Boston
OTHER
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary E. Cooley, Phd
Nurse Scientist, PhD, CRNP, FAAN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary E. Cooley, PhD, RN, FAAN
Role: PRINCIPAL_INVESTIGATOR
Dana Farber Cancer Insitute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham & Woman's Hospital
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-150
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.